Attention deficit hyperactivity disorder in adults. An overview;Aufmerksamkeitsdefizit-/hyperaktivitätsstörung (ADHS) bei erwachsenen: Ein überblick

Nervenarzt

Volumn 75, Issue 7, 2004, Pages 697-716

  Sobanski, E ^a   Alm, B ^a  

^a Sächsisches Krankenhaus   (Germany)

Author keywords

ADHD; Adults; Attention deficit hyperactivity disorder

Indexed keywords

AMFEBUTAMONE; DEXAMPHETAMINE; DOPAMINE 4 RECEPTOR; FENETYLLINE; METHYLPHENIDATE; NORADRENALIN; PEMOLINE; PSYCHOSTIMULANT AGENT;

ADULT; ADULTHOOD; ATTENTION DEFICIT DISORDER; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOPAMINERGIC TRANSMISSION; GERMANY; HUMAN; INTELLIGENCE QUOTIENT; NEUROBIOLOGY; NEUROPSYCHOLOGY; PREVALENCE; PSYCHOPHARMACOLOGY; PSYCHOTHERAPY; RATING SCALE; REVIEW;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CLINICAL TRIALS; COMBINED MODALITY THERAPY; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; DOPAMINE UPTAKE INHIBITORS; HUMANS; IMPULSE CONTROL DISORDERS; MENTAL DISORDERS; PSYCHOTHERAPY;

EID: 4344630960     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (105)

1. Still GF (1902) The Culostian lectures on some abnormal psychical conditions in children. Lancet: 1008-1012
2. Wender PH, Reimherr FW, Wood DR (1981) Attention deficit disorder ("minimal brain dysfunction") in adults. A replication study of diagnosis and treatment. Arch Gen Psychiatry 38:449-456
3. Krause KH, Krause J, Trott GE (1998) Das hyperkinetische Syndrom (Aufmerksamkeitsdefizit-/Hyperaktivitätssyndrom) des Erwachsenenalters. Nervenarzt 69:543-556
4. Ebert D, Krause J, Roth-Sackenheim C (2003) ADHS im Erwachsenenalter - Leitlinien auf der Basis eines Expertenkonsensus mit Unterstützung der DGPPN. Nervenarzt 10:939-946
5. Weiss G, Hechtman L, Milroy T et al. (1985) Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children. J Am Acad Child Adolesc Psychiatry 24:211-223
6. Manuzza S, Klein RG, Bessler A et al. (1993) Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 50(7):565-567
7. Rasmussen P, Gillberg C (2000) Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study. J Am Acad Child Adolesc Psychiatry 39(11):1424-1431
8. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. (DSM-IV). American Psychiatric Association, Washington DC
9. Steinhausen HC (2003) Attention-deficit hyperactivity disorder in a life perspective. Acta Psych Scand 107:321-322
10. Murphy K, Barkley RA (1996) Prevalence of DSM-IV symptoms of ADHD in adult license drivers: implication for clinical diagnosis. J Attention Dis 1:147-161
11. Heiligenstein E, Conyers LM, Berns AR et al. (1998) Preliminary normative data on DSM-IV attention-deficit hyperactivity disorder in college students. J Am Coll Health 46:185-188 18
12. Biedermann J, Faraone SV, Keenan K et al. (1990) Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder. J Am Acad Child Adolesc Psychiatry 29:526-533
13. Morrison JR, Stewart MA (1973) The psychiatric status of the legal families of adopted hyperactive children. Arch Gen Psychiatry 28:888-891
14. Sherman D, McGue M, Iacono W (1997) Twin concordance for attention deficit hyperactivity disorder. A comparison for teachers' and mothers' reports. Am J Psychiatry 154:532-535
15. Silberg J, Rutter M, Meyer J et al. (1996) Genetic and environmental influences on the the covariation between hyperactivity and conduct disturbance in juvenile twins. J Child Psychol Psychiatry 37:803-816
16. Faraone S, Biederman J (1998) Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry 44:951-958
17. Sprich S, Biederman J, Harding-Crawford M et al. (2000) Adoptive and biological families of children and adolescents with ADHD. J Am Acad Child Adolesc Psychiatry 39:1432-1437
18. Faraone SV (2000) Genetics of childhood disorders: XX. ADHD, Part 4. Is ADHD genetically heterogeneous? J Am Child Adolesc Psychiatry 39(11):1455-1457
19. Giros B, Jaber M, Jones SR et al. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamin transporter. Nature 379:606-612
20. Dulawa SC, Grandy DK, Low MJ et al. (1999) Dopamine D4 receptor-knock-out-mice exhibit reduced exploration of novel stimuli. J Neurosci 19:955-956
21. Benjamin J, Li L, Patterson C (1996) Population and family association between the D4 dopamine receptor gene and novelty seeking. Nat Genet 12:81-84
22. Ebstein RP, Nowick O, Umansky R (1996) Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking. Nat Genet 12:78-80
23. Barr CL, Wigg KG, Bloom S et al. (2000) Further evidence from haplotype analysis for linkage of the dopamine D4 receptor gene and attention deficit hyperactivity disorder. Am J Genet 12(3):262-267
24. Swanson J, Oosterlaan J, Murias M et al. (2000) Attention deficit/hyperactivity disorder children with a 7-repeat allele of the dopamine receptor D4 gene have extreme behavior but normal performance on critical neuropsychological tests of attention. Proc Natl Acad Sci USA 25(9):4754-4759
25. Faraone SV, Doyle AE, Mick E et al. (2001) Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry 158(7):1052-1057
26. Curran S, Mill J, Tahir E et al. (2001) Association study of dopamine transporter polymorphisms and attention deficit hyperactivity disorder in UK and Turkish samples. Mol Psychiatry 6(4):425-428
27. Comings DE, Gade-Andavolu R, Gonzalez N et al. (1999) Additive effect of the three noradrenergic genes (ADRA2A, ADRA2C, DBH) on attention-deficit hyperactivity disorder and learning disabilities in Tourette syndrome subjects. Clin Gent 55:160-172
28. Barr CL, Wigg K, Zai G et al. (2001) Attention deficit hyperactivity disorder and the adrenergic receptor alpha 1C and alpha 2C. Mol Psychiatry 6(3):334-337
29. Castellanos FX, Giedd JN, Marsh WL (1996) Quantitative brain magnetic resonance imaging in attention deficit/hyperactivity disorder. Arch Gen Psychiatry 53:607-616
30. Aylward EM, Reiss AH, Reader MJ (1996) Basal ganglia volumes in children with attention-deficit hyperactivity disorder. J Child Neurology 11:112-115
31. Berquin PC, Giedd JN, Jacobson LK (1999) The cerebellum in attention-deficit/hyperactivity disorder: a morphometric study. Neurology 50:1087-1093
32. Matarao M, Garcia-Sanchez C, Junque C et al. (1997) Magnetic resonance imaging measurement of the caudate nucleus in adolescents with attention-deficit/hyperactivity disorder and its relationship with neuropsychological and behavioral measures. Arch Neurology 54:963-968
33. Zametkin AJ, Nordahl TE, Gross M et al. (1990) Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med 323:1361-1366
34. Rubia K, Overmeyer S, Taylor E et al. (1999) Hypofrontality in attention-deficit hyperactivity disorder during high-order motor control: a study with functional MRI. Am J Psychiatry 156:891-896
35. Bush G, Frazier JA, Rauch SL et al. (1999) Anterior cingulate cortex dysfunction in attention deficit/hyperactivity disorder revealed by fMRI and the counting stroop. Biol Psychiatry 45:1542-1552
36. Ernst M, Zametkin AJ, Matochik J et al. (1998) DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A (fluorine-18)fluordopa positron emission tomographic study. J Neurosci 18:5901-5907
37. Krause KH, Dresel SH, Krause J et al. (2000) Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett 12, 285(2):107-110
38. Dougherty DD, Bonab AA, Spencer TJ et al. (1999) Dopamine transport density in patients with attention deficit hyperactivity disorder. Lancet 354:2132-1233
39. Barkley RA (2000) Genetics of childhood disorders: XVII. ADHD, Part 1: The executive functions and ADHD. J Am Acad Child Adolesc Psychiatry 39(8):1064-1066
40. Barkley RA (1997) Behavioral inhibition, sustained attention, and executive function: constructing a unifying theory of ADHD. Psychol Bull 121:65-94
41. Weltgesundheitsorganisation (1991) Internationale Klassifikation psychischer Störungen, ICD-10. Huber, Bern
42. Barkley RA, Biederman J (1997) Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder. J Am Acad Adolesc Psychiatry 36(9):1204-1210
43. Applegate B, Lahey BB, Hart EL et al. (2001) Validity of the age-of-onset criterion for ADHS: a report from the DSM-IV field trials. 40(5):502-504
44. Wender P (1995) Attention deficit hyperactivity disorder in adults. Oxford University Press, Oxford
45. Hesslinger B, Philipsen A, Richter H et al. (2003) Zur Psychotherapie der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) bei Erwachsenen. Verhaltenstherapie 13:276-282
46. Barkley RA, Murphy KR (1998) Attention deficit hyperactivity disorder: a clinical workbook. Guilford, New York
47. Krause J, Ryffel-Rawak (2000) Therapie der Aufmerksamkeitsdefizit-/ Hyperaktivitätsstörung im Erwachsenenalter. Psycho 26:209-223
48. Barkley RA, Murphy KR, Dupaul GJ et al. (2002) Driving in young adults with attention deficit hyperactivity disorder: knowledge, performance, adverse outcomes and the role of executive functioning. J Int Neuropsych Soc 8:655-672
49. Strohbeck-Kühner P, Alm B, Sobanski E et al. (2003) Die Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung: Eine neue Herausforderung an die Fahreignungsbegutachtung. Kongressbericht 2003 der Deutschen Gesellschaft für Verkehrsmedizin e.V.. Berichte der Bundesanstalt für Strassenwesen - Mensch und Sicherheit, Heft M 152:173-177
50. Alm B, Sobanski E (2003) Struktur und Inanspruchnah-mepopulation einer Spezialambulanz für Erwachsenen mit ADHS. Vortrag auf dem DGPPN-Kongress 2003
51. Shekim W, Asarnow RF, Hess E et al. (1990) A clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder, residual state. Compr Psychiatry 31(5):416-425
52. Biederman J, Faraone S, Spencer T et al. (1993) Patterns of psychiatric comorbidity, cognition and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 150(12):1792-1798
53. Marks DJ, Newcorn JH, Halperin JM (2002) Comorbidity in adults with attention-deficit/hyperactivity disorder. Ann N Y Acad Sci 216-233
54. Murphy K, Barkley RA (1996) Attention deficit hyperactivity disorder adults: comorbidities and adaptive impairments. Compr Psychiatry 37(6):393-401
55. Hesslinger B, Tebartz van Elst L, Mochan F et al. (2003) A psychopathological study into the relationship between attention deficit hyperactivity disorder in adult patients and recurrent brief depression. Acta Psychiatr Scand 107:385-389
56. Sachs GS, Baldassano CF, Truman O et al. (2000) Comorbidity of attention deficit hyperactivity disorder with early- and late-onset bipolar disorder. Am J Psychiatry 157(3):466-468
57. Biederman J, Faraone SV, Lapey K (1992) Comorbidity of diagnosis in attention deficit hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 2:335-361
58. Dodson WW, Zhan Y (1999) Sleep disturbances associated with adult ADHD. In: New Research Program and Abstracts of the 152nd Annual Meeting of the American Psychiatric Association, Washington, DC. Abstract NR 261:124
59. Kooij SJJ, Middelkoop HAM, van Gils K et al. (2001) The effect of stimulants on nocturnal motor activity and sleep quality in adults with ADHD: an open-label case-control study. J Clin Psychiatry 62:952-956
60. Carl C, Philipsen A, Burgos I et al. (2003) Die Schlafarchitektur bei erwachsenen Patienten mit Aufmerksamkeitsdefizit-/ Hyperaktivitätsstörungen. In: Abstract-band des DGPPN-Kongress 2003. Abstract Nr. 0663, 301
61. Brown TE, McMullen WJ Jr. (2001) Attention deficit disorders and sleep/arousal disturbances. Ann N Y Acad Sci 931:271-286
62. Mannuzza S, Klein RG, Blessler A et al. (1998) Adult psychiatric status of hyperactive boys grown up. Am J Psychiatry 155:493-498
63. Satterfield JH, Schell A (1997) A prospective study of hyperactive boys with conduct problems and normal boys: adolescent and adult criminality. J Am Acad Child Adolesc Psychiatry 36:1726-1735
64. Murphy KR, Barkley RA, Bush T (2002) Young adults with attention deficit hyperactivity diorder: subtype differences in comorbidity, educational and clinic history. J Nerv Ment Dis 190(3):147-157
65. Retz-Junginger P, Retz W, Blocher D et al. (2003) Reliabilität und Validität der Wender-Utah-Rating Scale-Kurzform. Nervenarzt 11:987-993
66. Brown TE (1996) Brown attention-deficit disorder scales manual. The Psychological Corporation, San Antonia
67. Conners CK, Erhardt D, Sparrow E (1999) Conners' Adult ADHD Rating Scales (CAARS). Multi Health Systems, Inc.
68. Wood PS, Lovejoy DW, Ball JD (2002) Neuropsychological characteristics in adults with ADHD: a comprehensive review of initial studies. Clin Neuropsychol 16(1):12-34
69. American Academy of Child and Adolescent Psychiatry (1997) Practice parameters for the assessment and treatment of children, adolescents and adults with attention deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 36:85S-121S
70. Wender PH (1998) Pharmacotherapy of attention-deficit/hyperactivity disorder in adults. J Clin Psychiatry 59(Suppl 7):76-79
71. Volkow ND, Wang GJ, Fowler JS et al. (1998) Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 155(10):1325-1331
72. Markowitz JS, Patrick KS (2001) Pharmakokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder. 40(10):753-772
73. Wilens TE (2003) Drug therapy for adults with attention-deficit hyperactivity disorder. Drugs 63(22):2395-2411
74. Fachinformation Ritalin (2002) Zusammenfassung der Merkmale des Arzneimittels/SPC
75. Santosh PJ, Taylor E (2000) Stimulant drugs. Eur Child Adolesc Psychiatry 9(1):27-43
76. Wood DR, Reimherr FW, Wender PH et al. (1976) Diagnosis and treatment of minimal brain dysfunction in adults. Arch Gen Psychiatry 33:1453-1460
77. Wender PH, Reimherr FW, Wood DR et al. (1985) A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type in adults. Am J Psychiatry 142:547-552
78. Gualteri CT, Ondrusek MG, Finley C (1985) Attention deficit disorder in adults. Clin Neuropsychopharmacol 8:343-356
79. Spencer T, Wilens TE, Biederman SV et al. (1995) A double-blind, cross-over comparison of methylphenidate and placebo in adults with childhood onset attention deficit hyperactivity disorder. Arch Gen Psychiatry 52:434-443
80. Biedermann J, Spencer T (2002) Methylphenidate in treatment of adults with attention deficit/hyperactivity disorder. J Attent Dis 6(1):101-107
81. Hornig-Rohan M, Amsterdam JD (2002) Venlafaxine versus stimulant therapy in patients with dual diagnosis and depression. Prog Neuropsychopharmacol Biol Psychiatry 26(3):585-589
82. Sobanski E, Alm B, Krumm B (2003) Methylphenidatwirkung bei erwachsenen Patienten mit ADHS unter Berücksichtigung von psychiatrischer Komorbidität und Subtyp. Abstractband DGPPN-Kongress 2003, Abstract-No. 0459
83. Winsberg BG, Comings DE (1999) Association of the dopamine transporter gene (DAT1) with poor methylphenidate response. J Am Acad Chil Adolesc Psychiatry 38(12):1474-1477
84. Gerlach M (2002) ADHS Stimulantien Therapie: Gefahr für Kinder und Jugendliche. Neurotransmitter 7/8:69-72
85. Biedermann J, Wilens T, Mick E (1999) Protective effects of ADHD pharmacotherapy on subsequent substance abuse: a longitudinal study. Pediatrics 104(2): e20
86. Loney J, Klahn M, Kosier T (1981) Hyperactive boys and their brothers at 21: predictors of aggresive and antisocial outcomes. Paper presented at the Society for Life History Research, Monterey, CA
87. Huss M (1999) Stimulant treatment in ADHD children lowers risk of drug abuse. In: Abstracts of the 11th International Congress of European Child and Adolescent Psychiatry (8) Suppl 2, Abstract 126
88. Levin FR, Evans SM, McDowell D et al (1997) Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study. J Clin Psychiatry 59:300-305
89. Diehl A, Sobanski E, Severa L et al. (2004) Alkoholabhängigkeit bei Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS): Rückfallschutz oder Suchtverlagerung durch Methylphenidat. Abstractband 120. Wanderversammlung Baden-Baden
90. Challman TD, Lipsky JJ (2000) Methylphenidate: it's pharmacology and use. Mayo Clin Proc 75:711-721
91. Pelham WE, Gnagy EM, Burows-Maclean L et al. (2001) Once-a-day concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics 107(6):1-115
92. Spencer T, Biederman J, Wilens T et al. (2001) Efficacy of a mixe amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 58(8):775-782
93. Wilens TE, Biederman J, Spencer TJ et al. (1999) Controlled trial of high doses of pemoline for adults with attention-deficit/hyperactivity disorder. J Clin Pharmacol 19(3):257-264
94. Becker K, Wehmeier P (2003) Atomoxetin zur Behandlung der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) bei Kindern, Jugendlichen und Erwachsenen. Psychoneuro 29(10):472-476
95. Spencer T, Biederman J, Wilens T et al. (1998) Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. Am J Psychiatry 111(5):693-695
96. Michelson D, Adler L, Spencer T et al. (2003) Atomoxetine in adults with ADHD: two ramdomized, placebo-controlled studies. Biol Psychiatry 53:112-120
97. Colla M, Alm B, Kronenberg G et al. (2004) Pharmaceutical treatment of ADHD with the specific NE reuptake inhibitor reboxetine (zur Veröffentlichung eingereicht)
98. Wilens TE, Biederman J, Prince J et al. (1996) Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry 153(9):1147-1153
99. Wilens TE, Biederman J, Mick E et al. (1995) A systematic chart review of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder. J Nerv Ment Dis 183(1):48-50
100. Wender PH, Reimherr FW (1990) Bupropion treatment of attention deficit hyperactivity disorder in adults. Am J Psychiatry 147:1018-1120
101. Wilens TE, Spencer TJ, Biederman J et al. (2001) A controlled clinical trial of bupropion für attention deficit hyperactivity disorder in adults. Am J Psychiatry 158:282-288
102. Adler LA, Resnick S, Kunz M et al. (1995) Open-label trial with venlafaxine in adults with attention deficit disorder. Psychopharmacology Bull 31(4):785-788
103. Normann C, Van Calker D, Vorderholzer U et al. (2003) Off-label-Indikationen in der Psychopharmakotherapie. Nervenarzt 9:815-823
104. Hesslinger B, Tebartz van Elst L, Nyberg E et al. (2002) Psychotherapy of attention deficit hyperactivity disorder in adults - a pilot study using a structured skill training program. Eur Arch Psychiatry Clin Neurosci 252:177-184
105. Stevenson CS, Whitmont S, Bornholt L et al. (2002) A cognitive remediation programme for adults with attention deficit hyperactivity disorder. Aus N Z J Psychiatry 36:610-616